Panel Discussion: A Unified Approach to Overcoming Challenges of CDx Development
- What are often critical and overlooked aspects when defining a strategy and preparing to support a clinical trial?
- How to address situations where there is a need to change a cut-off during the clinical trial?
- How to navigate the evolving global regulatory requirements?